SEC Form 6-K Summary
Filing issuer: China Jo-Jo Drugstores, Inc. The request metadata identifies Ridgetech Inc., which does not match the issuer named in the filing.
Reporting period: Month of April 2024; filed April 16, 2024. The filing reports an equity award effective April 1, 2024.
Business Context and Transaction
The Cayman Islands company furnished a Form 6-K reporting a grant of restricted stock awards under its Third Amended and Restated 2010 Equity Incentive Plan.
- The compensation committee granted 420,715 ordinary shares to Lei Liu, the company’s Chief Executive Officer and a director.
- The vesting conditions were waived, meaning the shares were granted without the stated vesting requirements.
- The shares were issued under an effective Form S-8 registration statement, File No. 333-277849, filed March 12, 2024.
Financial Metrics and Capital Structure
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, operating results, or financial guidance.
The filing does not state the award’s fair value, the resulting dilution percentage, or the company’s total shares outstanding after issuance.
Material Changes, Outlook, and Risks
The principal reported change is the issuance of 420,715 restricted ordinary shares to the CEO and director with vesting conditions waived. The filing provides no management outlook, risk-factor update, contingencies, or unusual operating items.
Investor Verification Items
- Verify the issuer identity because the filing names China Jo-Jo Drugstores, Inc., not Ridgetech Inc.
- Confirm the number of ordinary shares outstanding before and after the award and assess potential dilution.
- Review the equity incentive plan and Form S-8 for the award’s terms, accounting treatment, and any applicable restrictions.
- Confirm whether the waived vesting conditions result in immediate issuance and identify the related compensation expense.